[Calcium antagonists in therapy of arterial hypertension].
Calcium antagonists reduce the peripheral vascular resistance thus lowering an elevated blood pressure. Due to their properties they are regarded as basic antihypertensiva. They do not affect metabolism, cause a regression of left ventricular hypertrophy and improve the vascular compliance. Serious side effects are extremely rare. Because of their effects they are especially suitable for the therapy of arterial hypertension with certain attendant and resultant diseases of high blood pressure and with the existence of certain demographic factors like age and race.
Brandt
D
D
Sonderkrankenanstalt für Herz-Kreislauf-Erkrankungen St. Radegund.
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000503:physiopathology
D002121:Calcium Channel Blockers
Kalziumantagonisten in der Therapie der arteriellen Hypertonie.